Skip to main content

Hyperfine, Inc.

HYPR
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001833769

In the last 90 days, Hyperfine, Inc. insiders filed 0 open-market purchases and 2 sales; 80 institutions reported holding it in 13F filings for Q2 2026, worth $29.4M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Hyperfine, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of HYPR: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders40243+5
Shares10.8M94.7K10.9M+243.0K (+2.3%)
Value$7.78M$68.2K$15.9M+$8.18M (+106.1%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Hyperfine, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to HYPR in Q3 2025
InstitutionSharesValue% of portfolio
Jane Street Group, LLC124,720$180.8K0.00%
XTX Topco Ltd54,570$79.1K0.00%
Tortoise Investment Management, LLC45,000$65.3K0.01%
Royal Bank of Canada31,200$45.0K0.00%
Rockefeller Capital Management L.P.21,700$31.5K0.00%
Sanctuary Advisors, LLC17,300$25.1K0.00%
JPMorgan Chase & Co6,500$9.43K0.00%
Citigroup Inc1$10.00%

Sold out (3)

Institutions that held Hyperfine, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of HYPR in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Simplex Trading, LLC29,312$21.0K
Raymond James Financial Inc1,114$802
Cape Investment Advisory, Inc.200$144

Not filed for Q3 2025 yet (2)

Institutions that held Hyperfine, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HYPR in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Graypoint LLC60,000$43.2K
EP Wealth Advisors, LLC34,725$25.0K